Skip to main content

Table 1 Baseline characteristics of the patients

From: The relationship between fasting plasma glucose and MPO in patients with acute coronary syndrome

  Group A Group B Group C
N = 33 N = 23 N = 29
Age (year) 63 ± 10 68 ± 9 67 ± 10
Male/female(n) 18/15 12/11 20/9
BMI(kg/m2) 23.6 ± 0.4 23.5 ± 0.52 23.6 ± 0.3
Smoking, n (%) 20(61) 13(56) 19(69)
SBP(mmHg) 130 ± 4 127 ± 3 128 ± 3
DBP(mmHg) 76 ± 2 74 ± 2 75 ± 2
Leukocyte ( 109/L) 5.5 ± 1.95 6.7 ± 1.87* 7.18 ± 2.10*
Creatinine (μmol/L) 109.7 ± 9.6 99.38 ± 4.5 99.65 ± 5.88
TG(mmol/L) 2.05 ± 0.25 1.85 ± 0.22 2.8 ± 0.90
TC(mmol/L) 5.05 ± 0.18 4.54 ± 0.18 4.8 ± 0.12
LVEF (%) 0.59 ± .03 0.58 ± 0.02 0.57 ± 0.03
Gensini score 29.7(21.0–56.2) 35.1(23.8–55.0)* 43.6(22.0–56.0)*, **
Medications, n (%)    
Aspirin 13 (39) 10 (43) 11 (37)
β-blocker 15 (45) 11 (47) 14 (48)
ACEI/ARB 21 (67) 16 (76) 20 (68)
CCB 7 (22) 4 (19) 5 (17)
Nitrate 21 (63) 16 (69) 18 (62)
Statin 10 (30) 8 (34) 11 (37)
  1. Values are presented as mean ± SD. or n (%) or median
  2. BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; TG triglyceride; TC total cholesterol; LVEF left ventricular ejection fraction; ACEI angiotensin-converting enzyme inhibitors; ARB angiotensin II receptor blockers; CCB calcium channels blockers
  3. *P < 0.05 when compared with Group A; ** P < 0.05 when compared with Group B